Life Sciences Investment Showcase: Connecting Entrepreneurs With Expert Growth FacilitatorsAmy Cotterill2025-05-19T11:40:04+01:00March 23rd, 2023|Accelerator, Article, Investment|
New Platform Set To Accelerate Early-Stage Targeted Protein Degradation ProgrammesVicky Coghlan2024-11-28T14:07:30+00:00March 7th, 2023|Article, BioCity Nottingham, News|
Five Questions With Harry Pickering, Portfolio Director & Head Of UK InvestmentVicky Coghlan2024-11-28T14:48:26+00:00February 21st, 2023|Article, Headline Article, Investment|
Life Science Start-Up Report 2022 Launched By Pioneer Group And JLLGemma Cann2024-11-28T14:07:46+00:00April 11th, 2022|Article, Investment|
AbbVie Partners With Pioneer Group To Launch The Golden Ticket ProgrammeGemma Cann2024-11-28T14:08:06+00:00April 6th, 2022|Accelerator, Article, Investment, News|
Levelling Up White Paper And Life SciencesGemma Cann2024-11-28T14:08:19+00:00February 4th, 2022|Article|
Choosing To Challenge Access To Healthcare: I.W.D Interview With Anna MaxwellGemma Cann2024-11-28T14:08:37+00:00November 19th, 2021|Article|
Biotech Spinout Case Study: Kinomica – From Seed To Oversubscribed £3.9m Series A.Gemma Cann2024-11-28T14:08:54+00:00November 19th, 2021|Accelerator, Article|
The Epicentre Of The Drug Industry: How CROs Became The Backbone Of BiopharmaGemma Cann2024-11-28T14:09:23+00:00November 19th, 2021|Article|
Two Years Later: We Catch Up With Alex Birks, CEO Of Med-Tech Start-Up Suji BFRGemma Cann2024-11-28T14:19:34+00:00November 19th, 2021|Accelerator, Article|
